Deferasirox Tablet, For Suspension
Product Images NDC 46708-326

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Deferasirox (NDC 46708-326). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30 Tablets (Deferasirox 125mg)

Each tablet for oral suspension contains 125 mg of deferasirox. The usual dosage is indicated in the package insert. The product should be stored at 25°C (77°F), with excursions permitted to 15°C to 30°C (59°F to 86°F). The manufacturer is Alembic Pharmaceuticals Limited in India, and the product should be kept out of reach of children. The tablets must not be chewed or swallowed whole but dispersed in water, orange juice or apple juice prior to ingestion. Lot number B0 and the National Drug Code (NDC) are also provided.*

FDA Label Image

30 Tablets (Deferasirox 250mg)

Each tablet of the oral suspension contains 250 mg deferasirox. It is stored at room temperature and within the range of 15°C to 30°C. The drug is manufactured by Alembic Pharmaceuticals Limited in India with an NDC of 46708-325-30. It comes in a box of 30 tablets with instructions on how to take them. The tablets must not be chewed or swallowed whole but must be dispersed in water, orange or apple juice prior to ingestion. Keep out of the reach of children. Lot number B0 is indicated.*

FDA Label Image

30 Tablets (Deferasirox 500mg)

Each tablet of the described medicine contains 500 mg deferasirox. The usual dosage can be found in the package insert. The medicine should be stored at a temperature between 15°C to 30°C (59°F to 86°F). Alembic Pharmaceuticals Limited in Gujarat, India is the manufacturer of the medicine. The Medicine should be kept away from children. The medicine should not be swallowed or chewed whole, rather dispersed in either water, orange, or apple juice before ingestion. The text does not mention a lot number or expiry date.*

FDA Label Image

Figure 1 (Deferasirox Figure1)

FDA Label Image

Structure (Deferasirox Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.